Author Archives: Warren Woessner

Happy Birthday To Us – Patents4Life Is Five!

Posted on March 4, 2014 by Warren Woessner

Which actually seems a bit surprising, since this life sciences blog is pretty much the observations of one patent attorney – me – on developments in IP law. I do want to take the time to thank my fairly regular … Continue reading →

Posted in Miscellaneous | Tagged Bilski, biotechnology law, intellectual property, ip, Warren Woessner | 2 Comments

GlaxoSmithKline v. Banner Pharmacaps – Written Description Requirement 101

Posted on March 3, 2014 by Warren Woessner

In a short opinion dated February 24, 2014 (App. Nos. 2013-1593, -94, -95, -98), a Fed. Cir. panel made short work of the defendants’ attempt to invalidate a Glaxo claim in U.S. Pat. No. 5,565,467, to dutasteride “or a pharmaceutically … Continue reading →

Posted in Written Description Requirements (WDR) | Tagged Banner Pharmacaps, biotechnology, dutasteride, Federal Circuit, Glaxo, intellectual property, Patent Law, Warren Woessner | Leave a comment

Lightning Ballast II – Judge Lourie Tries to Get to “The Facts of the Matter”

Posted on February 24, 2014 by Warren Woessner

After reading all 88 pages of this very scholarly opinion which left patent law right where it was post-Cybor – no matter how much weight the parties and amici felt stare decisis deserved – I went back and read Judge Lourie’s concurrence. It is mercifully … Continue reading →

Posted in Claim Interpretation | Tagged biotechnology, cybor standard, Federal Circuit, intellectual property, Judge Lourie, Lightning Ballast, patent claims, Patent Law, Warren Woessner | Leave a comment

Federal Circuit Reaffirms Cybor Standard in Lightning Ballast Rehearing

Posted on February 21, 2014 by Warren Woessner

On Friday, a narrow majority of the Fed. Cir. sitting en banc, reaffirmed that claim interpretation is a question of law, to be reviewed de novo upon appeal to the Fed. Cir. (A copy of the decision can be found below.) … Continue reading →